Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Methods We searched PubMed, Embase, Cochrane and ClinicalTrials.gov up until 27 October 2021 for randomised controlled trials with a duration of at least 12 weeks that compared once-weekly tirzepatide 5, 10 or 15 mg with placebo or other glucose-lowering drugs in adults with type 2 diabetes irrespective of their background glucose-lowering treatment
Researchers noted that weight loss success, income level, medication costs and adverse effects were associated with decisions to continue or stop the medication
For people with type 2 diabetes, GLP-1 drugs can help in two key ways: they lower blood sugar levels and support weight loss
Product format This product is supplied as a lyophilised research compound
Druggable genome and drug repurposing potential Leveraging the Citeline PharmaProjects database (accessed October 2025), we identified two genes among the 12 candidate effector genes for ovarian cancer that are targeted by existing drug development programs
